AL

Abhishek Lakshmaiah Kuntegowdanahalli

Director Director DIN 06427258
DIN 06427258 First appointment Nov 2012 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Nov 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Abhishek Lakshmaiah Kuntegowdanahalli

Data last updated:

Abhishek Lakshmaiah Kuntegowdanahalli was a Director at Srinivasam Cancer Care Multi Speciality Hospitals India Private Limited (2012–2022). The company operates in Healthcare.

DIN 06427258
Primary Designation Director
Industry Healthcare
First Appointment 26 Nov 2012

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Nov 20122012₹37.3 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Srinivasam Cancer Care Multi Speciality Hospitals India Private Limited
Premium access

Shareholding and investment profile for Abhishek Lakshmaiah Kuntegowdanahalli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhishek Lakshmaiah Kuntegowdanahalli

Abhishek Lakshmaiah Kuntegowdanahalli was first appointed on 26 Nov 2012 as Director at Srinivasam Cancer Care Multi Speciality Hospitals India Private Limited.

Abhishek Lakshmaiah Kuntegowdanahalli held 1 earlier board appointment: Srinivasam Cancer Care Multi Speciality Hospitals India Private Limited (Director, 26 Nov 2012 to 31 Mar 2022).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available